C07C 62/30
Unsaturated compounds
C07C62/30 (Unsaturated compounds) appears on 358 US grants and 186 published applications in this corpus.
Search patents in C07C- Granted patents
- 358
- Published applications
- 186
- Assignees
- 209
- Inventors
- 842
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 11 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 7 | 0 |
| 1981 | 13 | 0 |
| 1982 | 17 | 0 |
| 1983 | 9 | 0 |
| 1984 | 4 | 0 |
| 1985 | 13 | 0 |
| 1986 | 3 | 0 |
| 1987 | 7 | 0 |
| 1988 | 8 | 0 |
| 1989 | 10 | 0 |
| 1990 | 7 | 0 |
| 1991 | 11 | 0 |
| 1992 | 13 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 17 | 0 |
| 1999 | 14 | 0 |
| 2000 | 7 | 0 |
| 2001 | 10 | 2 |
| 2002 | 9 | 9 |
| 2003 | 2 | 5 |
| 2004 | 3 | 8 |
| 2005 | 4 | 5 |
| 2006 | 4 | 6 |
| 2007 | 5 | 5 |
| 2008 | 4 | 9 |
| 2009 | 3 | 3 |
| 2010 | 3 | 12 |
| 2011 | 9 | 11 |
| 2012 | 9 | 4 |
| 2013 | 4 | 10 |
| 2014 | 8 | 9 |
| 2015 | 9 | 19 |
| 2016 | 8 | 11 |
| 2017 | 6 | 7 |
| 2018 | 11 | 12 |
| 2019 | 9 | 12 |
| 2020 | 4 | 7 |
| 2021 | 7 | 4 |
| 2022 | 1 | 3 |
| 2023 | 4 | 3 |
| 2024 | 3 | 3 |
| 2025 | 5 | 5 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds and compositions for treating conditions associated with LPA receptor activity30 Sep 2025US 12,428,375 B2Lhotse Bio, Inc.
- Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries26 Aug 2025US 12,397,008 B2Lead Billion Limited
- Ursolic acid morpholine salt19 Aug 2025US 12,391,726 B2Emmyon, Inc.
- Ursolic acid morpholine and diethanolamine salts1 Apr 2025US 12,264,178 B2Emmyon, Inc.
- Processes for preparing functionalized cyclooctenes14 Jan 2025US 12,194,100 B2Tambo, Inc.
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Compounds and compositions for treating conditions associated with lpa receptor activity18 Jun 2026US 2026/0167607 A1Lhotse Bio, Inc.
- Ursolic acid diethanolamine salt13 Nov 2025US 2025/0346627 A1Emmyon, Inc.
- Ursolic acid morpholine salt12 Jun 2025US 2025/0188114 A1Emmyon, Inc.
- Processes for preparing functionalized cyclooctenes1 May 2025US 2025/0135005 A1Tambo, Inc.
Most cited
By later US patents
- 17.beta.-N-monosubstituted carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones which are active as testosterone 5.alpha.-reductase inhibitors147US 4,760,071 AMerck & Co., Inc. · 1988
- Contact lens casting102US 5,158,718 APilkington Visioncare, Inc. · 1992
- Tricyclic-bis-enone derivatives and methods of use thereof88US 7,176,237 B2Trustees of Dartmouth College · 2007
- Arylphenyl-substituted cyclic keto-enols85US 6,417,370 B1Bayer Aktiengesellschaft · 2002
- Fused cyclooctyne compounds and their use in metal-free click reactions84US 8,859,629 B2Synaffix B.V. · 2014